Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Pharmalot
Biotech
Health
Politics

A letter from Executive Editor Rick Berke: All eyes on today’s drug pricing hearing

  • Rick Berke

By Rick Berke Feb. 26, 2019

Reprints
Pharma CEO photo illustration
Illustration: Alex Hogan/STAT; Photos: Abbvie, AP, Johnson & Johnson, Getty Images (2), BMS, Getty Images

A letter from Executive Editor Rick Berke: All eyes on today’s drug pricing hearing

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Rick Berke

Rick Berke

Co-founder & Executive Editor

Tags

J&J loses a patent battle in India over a…
J&J loses a patent battle in India over a crucial tuberculosis drug
There’s no autism epidemic. But there is an autism…
There’s no autism epidemic. But there is an autism diagnosis epidemic
J&J loses a patent battle in India over a…
J&J loses a patent battle in India over a crucial tuberculosis drug
Pharmalittle: FDA panel backs conditional approval for Biogen ALS…
Pharmalittle: FDA panel backs conditional approval for Biogen ALS drug; pharma fights tactic for lowering specialty…
Key senators blast Medicare Advantage insurers for ‘exorbitant salaries,’…
Key senators blast Medicare Advantage insurers for ‘exorbitant salaries,’ ‘massive payouts’ to execs
Former surgeon general Jerome Adams tries to outrun the…
Former surgeon general Jerome Adams tries to outrun the shadow of the president he served

Recommended Stories